Dawn E Quelle

15PUBLICATIONS
56CO-AUTHORS
Molecular targetsNutritional epidemiologyPredictive and prognostic markersNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 28, 2026
Development of a Cre-Inducible Rabl6a Transgenic Mouse Model That Enhances Sarcoma Growth In Vivo.

|Jul 29, 2025
Novel Therapeutics and the Path Toward Effective Immunotherapy in Malignant Peripheral Nerve Sheath Tumors.

Joshua J Lingo, Elizabeth C Elias, Dawn E Quelle

|Jun 06, 2025
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells.

Stacia L Koppenhafer, Elizabeth L Geary, Mary V Thomas

|May 22, 2025
Risk Factors Associated with Gastroenteropancreatic and Lung Neuroendocrine Tumors: A Nested Case-Control Study from the All of Us Research Program.

Tao Xu, Joseph S Dillon, Dawn E Quelle

|Jul 27, 2024
Functional Copy-Number Alterations as Diagnostic and Prognostic Biomarkers in Neuroendocrine Tumors.

Hayley Vaughn, Heather Major, Evangeline Kadera

|Jun 27, 2024
NF1+/ex42del miniswine model the cellular disruptions and behavioral presentations of NF1-associated cognitive and motor impairment.

Vicki J Swier, Katherine A White, Pedro L Negrão de Assis

Pageof 3

Frequent Collaborators

5 joint publications

Patrick J Breheny

4 joint publications

Chandra K Maharjan

4 joint publications

David K Meyerholz

4 joint publications

Rebecca D Dodd